{
  "image_filename": "table_p7_det_6_004.png",
  "image_path": "Hsiao_et_al.__2023_/extracted/figures/table_p7_det_6_004.png",
  "image_type": "Table",
  "page_number": 7,
  "block_id": "det_6_004",
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "supports_claim": false,
  "explanation": "Table listing baseline demographic and clinical characteristics (sex, race/ethnicity, coexisting illnesses, prior vaccination) of participants receiving recombinant versus standard-dose influenza vaccines The table only provides participant demographic and health characteristics and contains no information on vaccine production methods, mutations during manufacturing, or impacts on effectiveness, so it does not support the claim Note: The image is clear and fully captures the table content, which is limited to baseline characteristics and unrelated to the production or mutation potential of cell- or egg-based vaccines",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Table listing baseline demographic and clinical characteristics (sex, race/ethnicity, coexisting illnesses, prior vaccination) of participants receiving recombinant versus standard-dose influenza vaccines",
    "evidence_found": null,
    "reasoning": "The table only provides participant demographic and health characteristics and contains no information on vaccine production methods, mutations during manufacturing, or impacts on effectiveness, so it does not support the claim",
    "confidence_notes": "The image is clear and fully captures the table content, which is limited to baseline characteristics and unrelated to the production or mutation potential of cell- or egg-based vaccines"
  }
}